Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 15 May 2024 08:00 CEST |
PHOTOCURE | Photocure ASA: Results for the first quarter of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 12 May 2024 10:24 CEST |
PHOTOCURE | Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira in China | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 08 May 2024 22:36 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of first quarter 2024 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 07 May 2024 08:00 CEST |
PHOTOCURE | Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024 | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 30 Apr 2024 13:49 CEST |
PHOTOCURE | Photocure ASA - Notice of the Annual General Meeting 23 May 2024 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Apr 2024 11:52 CEST |
PHOTOCURE | Photocure ASA: Annual Report 2023 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 30 Apr 2024 07:30 CEST |
PHOTOCURE | Bladder Cancer: pivotal trial results and new real-world evidence, to be presented at AUA 2024, demonstrate improved diagnostic and clinical outcomes with blue light cystoscopy | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 25 Apr 2024 21:53 CEST |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 08 Apr 2024 12:33 CEST |
PHOTOCURE | European Association of Urology (EAU) 2024 congress features new data on modern technology use in bladder cancer care | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 05 Apr 2024 07:30 CEST |
PHOTOCURE | Photocure to Participate in the 23[rd] Annual Needham Virtual Healthcare Conference | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 28 Mar 2024 13:14 CET |
PHOTOCURE | New Publication: Racial Difference in Detection Rate of Bladder Cancer Using Blue Light Cystoscopy | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 18 Mar 2024 10:05 CET |
PHOTOCURE | Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 23 Feb 2024 08:35 CET |
PHOTOCURE | Photocure Partner Asieris to Unveil Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 SGO | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 22 Feb 2024 08:37 CET |
PHOTOCURE | Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 21 Feb 2024 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the fourth quarter of 2023 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 19 Feb 2024 09:29 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2023 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 29 Jan 2024 08:47 CET |
PHOTOCURE | Photocure Partner Asieris presented clinical trial and real-world data on Hexvix in China at ASCO GU 2024 | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 05 Jan 2024 08:51 CET |
PHOTOCURE | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Dec 2023 08:00 CET |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 11 Dec 2023 08:09 CET |
PHOTOCURE | Photocure ASA – Major shareholding disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 01 Dec 2023 07:30 CET |
PHOTOCURE | SUO 2023 Meeting: New Real World Evidence shows Significant Decrease in Risk of Bladder Cancer Recurrence with Blue Light Cystoscopy | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 29 Nov 2023 10:06 CET |
PHOTOCURE | Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 20 Nov 2023 17:50 CET |
PHOTOCURE | Photocure to present at four investor conferences in November/December 2023 | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 08 Nov 2023 08:00 CET |
PHOTOCURE | Photocure ASA: Results for the third quarter of 2023 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 01 Nov 2023 08:22 CET |
PHOTOCURE | Photocure ASA: Invitation to presentation of third quarter 2023 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 12 Oct 2023 10:32 CEST |
PHOTOCURE | Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 08 Oct 2023 15:44 CEST |
PHOTOCURE | Photocure Partner Asieris to present first results for its Hexvix Phase III clinical trial in China at the SIU 2023 Annual Meeting | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 06 Oct 2023 15:07 CEST |
PHOTOCURE | New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 02 Oct 2023 13:29 CEST |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 27 Sep 2023 18:06 CEST |
PHOTOCURE | Photocure ASA: Change of Board Composition | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Sep 2023 13:59 CEST |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 20 Sep 2023 12:17 CEST |
PHOTOCURE | Photocure Partner Asieris announces that the First Non-Vaccine Investigational Product for Cervical HSIL has Achieved Its Primary Endpoint | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 30 Aug 2023 16:06 CEST |
PHOTOCURE | Photocure ASA: Notification of primary insider transaction | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 11 Aug 2023 11:05 CEST |
PHOTOCURE | Photocure Partner Asieris confirms Hexvix Phase III clinical trial in China meets endpoint | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 09 Aug 2023 08:00 CEST |
PHOTOCURE | Photocure ASA: Results for the second quarter and first half of 2023 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 08 Aug 2023 14:26 CEST |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 03 Aug 2023 08:13 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of second quarter and first half year 2023 financial results | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 Jul 2023 10:40 CEST |
PHOTOCURE | Photocure Partner Asieris announces completion of enrollment for Hexvix Phase III clinical trial in China | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 01 Jun 2023 14:36 CEST |
PHOTOCURE | Major shareholder disclosure | 20103015 Pharmaceuticals | Major shareholding notifications |
| 24 May 2023 08:32 CEST |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 10 May 2023 08:00 CEST |
PHOTOCURE | Photocure ASA: Results for the first quarter of 2023 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 04 May 2023 13:22 CEST |
PHOTOCURE | Photocure ASA - Correction: Annual general meeting held | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 May 2023 18:41 CEST |
PHOTOCURE | Photocure ASA - Annual general meeting held | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 03 May 2023 11:38 CEST |
PHOTOCURE | Photocure ASA: Invitation to presentation of first quarter 2023 financial results | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 12 Apr 2023 16:01 CEST |
PHOTOCURE | Photocure ASA: Annual Report 2022 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 12 Apr 2023 16:01 CEST |
PHOTOCURE | Photocure ASA - Notice of the Annual General Meeting 3 May 2023 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Apr 2023 08:09 CEST |
PHOTOCURE | Major shareholder disclosure - Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 04 Apr 2023 13:55 CEST |
PHOTOCURE | Major shareholder disclosure in Photocure ASA | 20103015 Pharmaceuticals | Major shareholding notifications |
| 30 Mar 2023 10:48 CEST |
PHOTOCURE | Photocure ASA - Share option grant | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Mar 2023 21:57 CET |
PHOTOCURE | Photocure provides update on Karl Storz's commitment to maximize the commercial adoption of SaphiraT and decision to discontinue flexible BLC tower production in the U.S. | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |